Legal & General Group Plc Has $17.10 Million Stock Holdings in HealthEquity, Inc. $HQY

Legal & General Group Plc grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 9.3% in the second quarter, Holdings Channel reports. The institutional investor owned 163,248 shares of the company’s stock after acquiring an additional 13,924 shares during the period. Legal & General Group Plc’s holdings in HealthEquity were worth $17,102,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Farther Finance Advisors LLC lifted its position in HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after acquiring an additional 172 shares in the last quarter. WPG Advisers LLC purchased a new stake in shares of HealthEquity in the first quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of HealthEquity in the second quarter valued at approximately $33,000. Cullen Frost Bankers Inc. lifted its holdings in shares of HealthEquity by 172.3% in the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after purchasing an additional 224 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its position in shares of HealthEquity by 176.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock valued at $58,000 after buying an additional 418 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Performance

Shares of HQY stock opened at $104.58 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The firm has a market cap of $9.01 billion, a price-to-earnings ratio of 63.38, a P/E/G ratio of 1.36 and a beta of 0.47. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The firm’s 50-day simple moving average is $96.11 and its two-hundred day simple moving average is $96.84.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $325.80 million during the quarter, compared to the consensus estimate of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, equities analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president directly owned 49,795 shares in the company, valued at $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $104.56, for a total value of $156,840.00. Following the transaction, the executive vice president owned 75,479 shares of the company’s stock, valued at $7,892,084.24. The trade was a 1.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 10,781 shares of company stock valued at $1,016,707 over the last three months. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of analyst reports. Jefferies Financial Group increased their price target on HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. BMO Capital Markets began coverage on shares of HealthEquity in a report on Thursday, November 13th. They issued a “market perform” rating and a $100.00 target price for the company. JPMorgan Chase & Co. boosted their price target on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, September 3rd. KeyCorp reduced their price objective on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Finally, Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $119.00.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.